These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7011735)
1. Biologic activity and pharmacokinetics of biosynthetic human insulin in the rat. Halban PA; Berger M; Gjinovci A; Renold AE Diabetes Care; 1981; 4(2):238-43. PubMed ID: 7011735 [TBL] [Abstract][Full Text] [Related]
2. Comparison of biosynthetic human insulin and pork insulin in the Gerritzen test. Weinges K; Ehrhardt M; Enzmann F Diabetes Care; 1981; 4(2):180-2. PubMed ID: 7011722 [TBL] [Abstract][Full Text] [Related]
3. Immunologic properties of biosynthetic human insulin in vitro. Beischer W; Maier V; Jonatha EM; Hartweg D; Kratzsch G Diabetes Care; 1981; 4(2):202-4. PubMed ID: 7011727 [TBL] [Abstract][Full Text] [Related]
4. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers. Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919 [TBL] [Abstract][Full Text] [Related]
5. Receptor binding of biosynthetic human insulin on isolated pig hepatocytes. Gammeltoft S Diabetes Care; 1981; 4(2):235-7. PubMed ID: 7011734 [TBL] [Abstract][Full Text] [Related]
6. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes. Peavy DE; Abram JD; Frank BH; Duckworth WC Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667 [TBL] [Abstract][Full Text] [Related]
7. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin. Olefsky JM Diabetes Care; 1981; 4(2):244-7. PubMed ID: 7011736 [TBL] [Abstract][Full Text] [Related]
8. Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin. Federlin K; Laube H; Velcovsky HG Diabetes Care; 1981; 4(2):170-4. PubMed ID: 7011720 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system. Klier M; Kerner W; Torres AA; Pfeiffer EF Diabetes Care; 1981; 4(2):193-5. PubMed ID: 7011725 [TBL] [Abstract][Full Text] [Related]
10. Studies on the biologic actions of biosynthetic human insulin in vitro and in diabetic man. Waldhäusl WK; Kastner G; Komjati M; Bratusch-Marrain P Diabetes Care; 1981; 4(2):205-8. PubMed ID: 7011728 [TBL] [Abstract][Full Text] [Related]
11. Degradation of pork insulin and biosynthetic human insulin in vitro and in vivo: a comparative study. Halban PA; Duckworth WC Endocr Res Commun; 1981; 8(2):127-34. PubMed ID: 7028460 [TBL] [Abstract][Full Text] [Related]
12. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique. Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009 [TBL] [Abstract][Full Text] [Related]
13. An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus. Gerich JE Diabetes Care; 1981; 4(2):262-4. PubMed ID: 7011743 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects. Massi-Benedetti M; Burrin JM; Capaldo B; Alberti KG Diabetes Care; 1981; 4(2):163-7. PubMed ID: 7011718 [TBL] [Abstract][Full Text] [Related]
15. Internalization of 125I-insulin by IM-9 cultured human lymphocytes: a comparison between A14-monoiodo-pork and biosynthetic human insulin. Carpentier JL; Halban PA; Renold AE; Orci L Diabetes Care; 1981; 4(2):220-2. PubMed ID: 7011731 [TBL] [Abstract][Full Text] [Related]
16. Biosynthetic human insulin: effect in healthy men on plasma glucose and non-esterified fatty acids in comparison with highly purified pork insulin. Viberti GC; Pickup JC; Keen H; Bilous RW; Mattock M; Jarrett RJ; Glynne A; Rogers R Diabetes Care; 1981; 4(2):175-9. PubMed ID: 7011721 [TBL] [Abstract][Full Text] [Related]
17. The plasma glucose response of normal fasting subjects to neutral regular and NPH biosynthetic human and purified pork insulins. Galloway JA; Spradlin CT; Root MA; Fineberg SE Diabetes Care; 1981; 4(2):183-8. PubMed ID: 7011723 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA). Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967 [TBL] [Abstract][Full Text] [Related]
19. Potency of biosynthetic human insulin determined in vitro. Fussgaenger RD; Ditschuneit HH; Martini H; Wiebauer-De Lenardis H; Etzrodt H; Thun C; Ditschuneit H; Pfeiffer EF; Enzmann F Diabetes Care; 1981; 4(2):228-34. PubMed ID: 7011733 [TBL] [Abstract][Full Text] [Related]
20. Relative potencies of human and pork insulin during i.v. and oral glucose tolerance test in lean and obese persons. Nesher R; Sinai J; Litvin Y; Cerasi E Isr J Med Sci; 1985 Nov; 21(11):905-11. PubMed ID: 3908398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]